cafepharma

To submit an article, first register a user account. Then click "create content" on the navbar (this will appear when you are logged in).

CP Wire Articles

IPE Kicks Off Phase 2 Clinical Trial for New Hypothyroid Drug

Wed, 06/12/13 - 9:53 am

Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications

Mon, 06/10/13 - 10:31 am

France ignores EMA and suspends Bayer acne treatment Diane 35

Tue, 05/21/13 - 9:45 am

New Study Reports Key Findings for the ABThera™ Open Abdomen Negative Pressure Therapy System

Thu, 05/16/13 - 1:41 pm

Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi

Mon, 05/13/13 - 10:59 am

Independent Study Showed Decrease in Operating Room Visits for Patients with Infected Wounds using Adjunctive V.A.C. VeraFlo™ Therapy

Wed, 05/08/13 - 6:33 pm

KCI Announces Global Rollout of Novel Skin Graft Harvesting Tool

Mon, 04/29/13 - 10:01 am

Labeling Considerations in the European Union and its Impact on Global Labeling Compliance

Thu, 02/21/13 - 3:41 pm

IPE receives FDA approval for Phase 2 clinical trials for BCT303 for hypothyroidism

Wed, 01/30/13 - 2:19 pm

Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer

Fri, 01/04/13 - 12:03 pm

Discovery Labs Initiates Launch of AFECTAIR®

Fri, 01/04/13 - 12:01 pm

KCI Acquires New Skin Grafting Technology

Tue, 12/18/12 - 6:55 pm

Another door closes on Abbott

Wed, 12/12/12 - 9:01 am

Assessing Innovative Specialized Models for Pediatrics and Neonatal Patients

Tue, 12/11/12 - 11:35 am

Pacific BioLabs Acquires Bay Bioanalytical Laboratory

Thu, 11/15/12 - 6:45 pm

Alnylam Pharmaceuticals, BioMarin Pharmaceutical Inc., and Cytonet Set to Speak on Conducting Effective Orphan Drug Research

Thu, 11/15/12 - 1:32 pm

Deciphering the Sunshine Act

Wed, 10/24/12 - 8:14 am

INC Research to host Live Event: Recent Diabetes Studies – Implications for Clinical Practice

Tue, 10/23/12 - 11:21 am

Pfenex Inc. Awarded Contract by the National Institute of Allergy and Infectious Diseases (NIAID) to Develop an Alternative Delivery Method for its Recombinant Protective Antigen (rPA) based Anthrax Vaccine

Wed, 10/17/12 - 1:03 pm

Pharmaceutical industry shares new policy recommendations to address growing burden of mental and neurological disorders (MNDs)

Thu, 10/11/12 - 3:50 am